We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$189B
AUM Growth
-$8.13B
Cap. Flow
+$2.76B
Cap. Flow %
1.46%
Top 10 Hldgs %
23.87%
Holding
8,193
New
1,492
Increased
2,451
Reduced
2,453
Closed
1,365

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.35B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.32B
3
AAPL icon
Apple
AAPL
+$966M
4
NVDA icon
NVIDIA
NVDA
+$768M
5
T icon
AT&T
T
+$594M

Sector Composition

Rank Sector Weight
1 Technology 7.17%
2 Financials 6.59%
3 Healthcare 6.12%
4 Industrials 4.26%
5 Consumer Discretionary 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEON.WS
6426
CALL
DELISTED
AEON Biopharma Inc
AEON.WS
$36K ﹤0.01%
121,333
-65,077
-35% -$26.8K
NMMCW
6427
CALL
DELISTED
North Mountain Merger Corp. Warrant
NMMCW
$36K ﹤0.01%
125,000
GDEV
6428
DELISTED
Nexters Inc. Ordinary Shares
GDEV
$36K ﹤0.01%
46,519
-5,334
-10% -$41.2K
DBVT
6429
DBV Technologies
DBVT
$852M
$35K ﹤0.01%
+2,212
New +$33.4K
EVLVW
6430
CALL
DELISTED
Evolv Technologies Warrant
EVLVW
$35K ﹤0.01%
93,750
FEED
6431
ENvue Medical Inc
FEED
$2.28M
$35K ﹤0.01%
+14
New +$26.4K
PETZ icon
6432
TDH Holdings
PETZ
$12.4M
$35K ﹤0.01%
3,937
+1,894
+93% +$27.4K
PLG
6433
Platinum Group Metals
PLG
$188M
$35K ﹤0.01%
+16,689
New +$32.2K
ENSV
6434
DELISTED
Enservco Corp.
ENSV
$35K ﹤0.01%
13,098
-4,382
-25% -$6.86K
ORGS
6435
DELISTED
Orgenesis Inc. Common Stock
ORGS
$35K ﹤0.01%
1,000
-1,184
-54% -$36K
HCMAW
6436
CALL
DELISTED
HCM Acquisition Corp Warrant
HCMAW
$35K ﹤0.01%
+175,000
New +$37.2K
NSTB.WS
6437
CALL
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
$35K ﹤0.01%
83,220
-2,260
-3% -$1.13K
CFIVW
6438
CALL
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
$35K ﹤0.01%
86,741
-10,833
-11% -$5.09K
ILLM
6439
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$35K ﹤0.01%
11,200
-60,611
-84% -$174K
BNNRW
6440
CALL
DELISTED
Banner Acquisition Corp. Warrants
BNNRW
$35K ﹤0.01%
+83,600
New +$36.5K
BIOTW
6441
CALL
DELISTED
Biotech Acquisition Company Warrant
BIOTW
$35K ﹤0.01%
+146,293
New +$46.7K
RXRAW
6442
CALL
DELISTED
RXR Acquisition Corp. Warrants to purchase Class A common stock
RXRAW
$35K ﹤0.01%
78,000
-340,039
-81% -$178K
OHPAW
6443
CALL
DELISTED
Orion Acquisition Corp. Warrant
OHPAW
$35K ﹤0.01%
112,825
-15,497
-12% -$6.63K
TSIBW
6444
CALL
DELISTED
Tishman Speyer Innovation Corp. II Warrant
TSIBW
$35K ﹤0.01%
91,633
-8,362
-8% -$4.07K
LUXAW
6445
CALL
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
$35K ﹤0.01%
83,333
SCNI
6446
Scinai Immunotherapeutics
SCNI
$1.28M
$34K ﹤0.01%
+202
New +$29.3K
LOGC
6447
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$34K ﹤0.01%
50,285
-84,742
-63% -$93K
ASAQ.WS
6448
CALL
DELISTED
Atlantic Avenue Acquisition Corp Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ASAQ.WS
$34K ﹤0.01%
156,250
CRU.WS
6449
CALL
DELISTED
Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CRU.WS
$34K ﹤0.01%
98,333
PNST.WS
6450
CALL
DELISTED
Pinstripes Holdings, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
PNST.WS
$33K ﹤0.01%
+175,000
New +$31.8K

Similar funds

Millennium Management's Q1 2022 Portfolio in Review

As of Q1 2022, Millennium Management held 8,193 positions worth $189B, down 4.1% from $197B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Millennium Management's Q1 2022 filing shows 1,492 new, 2,451 increased, 2,453 reduced and 1,365 closed positions. Its largest new stake was Mondelez International: 1,780,636 shares worth $112M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.35B.

By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.9% a quarter earlier, followed by Financials and Healthcare.

  • Millennium Management's largest Q1 2022 buy was Mondelez International: 1,780,636 shares worth $112M.
  • Millennium Management added most to iShares MSCI Emerging Markets ETF in Q1 2022, an estimated $554M increase.
  • Millennium Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.35B.
  • Millennium Management fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $532M.
  • Millennium Management's ten largest holdings make up 24% of its $189B portfolio in Q1 2022.
  • Millennium Management opened 1,492 new positions and closed 1,365 in Q1 2022.
  • Millennium Management's portfolio value fell 4.1% quarter-over-quarter to $189B.

Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.